Sofia, Bulgaria, January 11, 2021 – According to the requirements of art. 100t of LPOS, “Sopharma” AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) notifies that for December 2020 the Company recorded an increase in sales of 27% compared to the same month of 2019, incl. 1% increase of domestic sales and 63% increase of export sales. For the twelve months of 2020 the revenues from sales of production decrease by 11% compared to the same period of 2019, incl. 24% decrease of sales on the domestic market and 2% decrease of export sales.